Science & Enterprise subscription

Follow us on Twitter

  • Ooops ... https://t.co/G7nkwRtOS8
    about 5 hours ago
  • An international health coalition is funding development of vaccines against the new coronavirus outbreak spreading… https://t.co/6qO4xiglnc
    about 11 hours ago
  • New post on Science and Enterprise: Int’l Group Funding Coronavirus Vaccines https://t.co/lfGeJgppxy #Science #Business
    about 11 hours ago
  • A bio-compatible conduit is shown in tests with monkeys to promote regrowth of damaged nerve fibers, like those suf… https://t.co/Gqt6JkCEil
    about 15 hours ago
  • New post on Science and Enterprise: Implanted Guide Helps Regrow Damaged Body Nerves https://t.co/hlmKUMfNBI #Science #Business
    about 15 hours ago

Please share Science & Enterprise

Implanted Guide Helps Regrow Damaged Body Nerves

Nerve cells illustration

A bio-compatible conduit is shown in tests with monkeys to promote regrowth of damaged nerve fibers, like those suffered in traumatic injuries. . . . → Read More: Implanted Guide Helps Regrow Damaged Body Nerves

Pharma Gains Fibrosis Technology in $1B+ Deal

Stuart Cook

Drug maker Boehringer Ingelheim is acquiring an antibody technology that blocks actions of a signaling protein associated with a range of fibrosis diseases. . . . → Read More: Pharma Gains Fibrosis Technology in $1B+ Deal

Biotech Options Enzyme Inhibitors for Lung Cancer

Human lungs illustration

A biotechnology company developing inhaled drugs for respiratory diseases agreed to provide Johnson & Johnson with access to its technology for treating lung cancer. . . . → Read More: Biotech Options Enzyme Inhibitors for Lung Cancer

Engineered Viruses Licensed for Cancer Therapies

Vaccinia virus

A biotechnology company developing cancer immunotherapies with synthetic viruses is licensing its technology to Takeda Pharmaceuticals. . . . → Read More: Engineered Viruses Licensed for Cancer Therapies

Engineered Virus Aids Gene Therapy Delivery

Adeno-associated virus

A university bio-engineering lab and start-up company are developing synthetic variations of viruses to more reliably deliver gene therapies. . . . → Read More: Engineered Virus Aids Gene Therapy Delivery

Biotech Licenses Gene-Limiting Technology for Allergies

DNA puzzle

A biotechnology company developing treatments for skin conditions is acquiring a technology for limiting effects of genes causing asthma and allergic reactions. . . . → Read More: Biotech Licenses Gene-Limiting Technology for Allergies

Company, Univ. Lab Partner on Skin Disease Treatment

Spray bottle

A company making regenerative skin therapies and a medical school research center are developing a spray-on treatment for a genetic skin disorder. . . . → Read More: Company, Univ. Lab Partner on Skin Disease Treatment

FDA Tags Biofilm Disruption Device as Breakthrough

MRSA bacteria

A system using an electric current to break up bacterial communities on orthopedic implants received a breakthrough-device designation from the Food and Drug Administration. . . . → Read More: FDA Tags Biofilm Disruption Device as Breakthrough

Trial Shows Nanotech Drug Induces Gluten Tolerance

bread and rolls

Results from a clinical trial show an experimental treatment encourages immune-system tolerance of gluten, preventing intestinal damage from celiac disease. . . . → Read More: Trial Shows Nanotech Drug Induces Gluten Tolerance

Merck Gaining Gut Microbe Technology for Vaccines

Microbiome graphic

Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines. . . . → Read More: Merck Gaining Gut Microbe Technology for Vaccines